Preclinical Toxicological Study of Release-Active Preparations for Prediction of Their Pharmacological Activity and Side Effects.

Autor: Zhavbert ES; Materia Medica Holding, Moscow, Russia. zhavbertes@materiamedica.ru., Surkova EI; Materia Medica Holding, Moscow, Russia., Yakovleva NN; Materia Medica Holding, Moscow, Russia., Dugina YL; Materia Medica Holding, Moscow, Russia., Epshtein OI; Materia Medica Holding, Moscow, Russia., Bugaeva LI; Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russia., Lebedeva SA; Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russia., Petrov VI; Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2016 Jun; Vol. 161 (2), pp. 252-6. Date of Electronic Publication: 2016 Jul 07.

The Use of Release-Active Antibody-Based Preparations for Vertigo Prevention in Adults.

Autor: Barchukov VV; Materia Medica Holding, Moscow, Russia., Zhavbert ES; Materia Medica Holding, Moscow, Russia. zhavbertes@materiamedica.ru., Dugina YL; Materia Medica Holding, Moscow, Russia., Epstein OI; Materia Medica Holding, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2015 Nov; Vol. 160 (1), pp. 61-3. Date of Electronic Publication: 2015 Nov 25.

[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].

Autor: Ganina KK; ООО 'NPF 'Materia Medica Holding'., Dugina YL; ООО 'NPF 'Materia Medica Holding'., Zhavbert ES; ООО 'NPF 'Materia Medica Holding'., Ertuzun IA; ООО 'NPF 'Materia Medica Holding'., Epstein OI; ООО 'NPF 'Materia Medica Holding'., Abdurasulova IN; FSBSI 'Institute of Experimental Medicine', Moscow.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2015; Vol. 115 (6), pp. 78-82.

Some aspects of toxicological activity of kardosten after chronic 6-month administration to rats.

Autor: Petrov VI; Department of Pharmacology, S M Kirov Military Medical Academy, St. Petersburg, Russia., Bugaeva LI, Lebedeva SA, Lavrova EV, Dugina YL, Kheifets IA, Zabolotneva YA, Sergeeva SA, Epstein OI

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2010 Dec; Vol. 150 (2), pp. 215-8.

Effect of ultralow doses of antibodies to S-100 protein in animals with impaired cognitive function and disturbed emotional and neurological status under conditions of experimental Alzheimer disease.

Autor: Voronina TA; Materia Medica Holding Research-and-Production Company, Moscow., Belopol'skaya MV, Kheyfets IA, Dugina YL, Sergeeva SA, Epshtein OI

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2009 Sep; Vol. 148 (3), pp. 533-5.